sST2: a new kid on the block for patients with ACHD

Adults with congenital heart disease (ACHD) are an increasing and ageing population.1 Despite all advances in medical and surgical treatment, patients with ACHD are still afflicted by significant morbidity and mortality.2 Timely identification of those patients that are at risk can be difficult. In acquired cardiovascular disease, biomarkers play an important role for the diagnosis and even for monitoring the treatment. Brain natriuretic...